ArticleFrontiers in oncology2023
Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study.
Marilda Mormando et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it